Neuroscience-based Nomenclature (NbN) as a Teaching Tool

Medical Education Clinical Trial

Official title:

The Effect of the Use Of Neuroscience-based Nomenclature (NbN) In The Teaching Of Psychopharmacology on Medical Students Views Toward Psychiatry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04375254
• Other study ID #: 0103wrqw2030
• Status: Recruiting
• Start date: May 1, 2020
• Est. completion date: September 2021

Study information

• Verified date: March 2021
• Source: Hebrew University of Jerusalem
• Contact: Daniel Levy, MD
• Phone: 0508929655
• Email: DANIEL[@]MINKINLEVY.COM
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In recent decades, medical student interest in a career in mental health appear to be in decline, possibly due to the perception that the scientific foundation of psychiatry and psychopharmacology is weaker compared to other fields of medicine. In an effort to examine ways of improving the current nomenclature in Psychopharmacology, in 2008 the nomenclature taskforce was initiated, composed of representatives from five international organizations: ECNP - European College of Neuropsychopharmacology, ACNP - American College of Neuropsychopharmacology, AsCNP - Asian College of Neuropsychopharmacology, CINP - International College of Neuropsychopharmacology, IUPHAR - International Union of Basic and Clinical Pharmacology.2 The result of this effort is the Neuroscience based Nomenclature (NbN) - a pharmacologically driven nomenclature that focuses on reflecting current knowledge and on the understanding of the neural system being modified this research is the first that examine whether putting greater emphasis on neuroscience in the teaching of psychotropics, through the use of the new NbN terminology, achieve the goal of improving medical students views on psychiatry.

Description:

In recent decades, medical student interest in a career in mental health appear to be in decline1. There are multiple factors responsible for the apparent lack of interest in psychiatry, one of them may be the perception that the scientific foundation of psychiatry and psychopharmacology is weaker compared to other fields of medicine. As the field of psychopharmacology evolves, the terminology used to describe different classes of medication becomes increasingly convoluted: at a time when the same agent is used for the treatment of several different disorders, the nomenclature in use is indication-based and divided into classes that are disease based - such as Antidepressant, Antipsychotic and Anxiolytics. These classes, in turn, are divided into subclasses like "Atypical" or "Second Generation" - terms that give little information regarding the pharmacological properties of the medication itself. This discrepancy between the current naming of psychotropics and the way they are used in clinical practice is confusing to both the clinician and the patient - and since it fails to reflect on the current scientific knowledge, may affect the way young medical professionals perceive the profession of psychiatry. In an effort to examine ways of improving the current nomenclature in Psychopharmacology, in 2008 the nomenclature taskforce was initiated, composed of representatives from five international organizations: ECNP - European College of Neuropsychopharmacology, ACNP - American College of Neuropsychopharmacology, AsCNP - Asian College of Neuropsychopharmacology, CINP - International College of Neuropsychopharmacology, IUPHAR - International Union of Basic and Clinical Pharmacology.2 The result of this effort is the Neuroscience based Nomenclature (NbN) - a pharmacologically driven nomenclature that focuses on reflecting current knowledge and on the understanding of the neural system being modified (''pharmacological domain'') and its mode/mechanism of action (''mode of action'')3. The NbN was widely accepted by both clinicians and leading psychiatric journals4 The need to revise the teaching methods of psychopharmacology was reviewed over the years, with different strategies suggested5. To our knowledge, this research is the first that examine whether putting greater emphasis on neuroscience in the teaching of psychotropics, through the use of a new terminology, achieve the goal of improving medical students views on psychiatry.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: September 2021
• Est. primary completion date: August 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

Medical students during fifth year psychiatry clerkship Exclusion Criteria: none

Related Conditions & MeSH terms

• Medical Education

Intervention

Other:
• NbB psychopharmacology training
a two part course in psychopharmacology based on Neuroscience based Nomenclature

Locations

Country	Name	City	State
Israel	Jerusalem Center for Mental Health	Jerusalem

Sponsors (2)

Lead Sponsor	Collaborator
Hebrew University of Jerusalem	Jerusalem Mental Health Center

Country where clinical trial is conducted

Israel, 

References & Publications (5)

Tamaskar P, McGinnis RA. Declining student interest in psychiatry. JAMA. 2002 Apr 10;287(14):1859. — View Citation

The Lancet Psychiatry. Naming names. Lancet Psychiatry. 2016 Jun;3(6):489. doi: 10.1016/S2215-0366(16)30072-4. — View Citation

Zisook S, Glick ID, Jefferson JW, Wagner KD, Salzman C, Peselow ED, Stahl S. Teaching psychopharmacology: what works and what doesn't. J Clin Psychopharmacol. 2008 Feb;28(1):96-100. doi: 10.1097/jcp.0b013e3181603f6b. — View Citation

Zohar J, Kasper S. Neuroscience-based Nomenclature (NbN): A call for action. World J Biol Psychiatry. 2016 Aug;17(5):318-20. doi: 10.1080/15622975.2016.1193626. Epub 2016 Jul 5. — View Citation

Zohar J, Nutt DJ, Kupfer DJ, Moller HJ, Yamawaki S, Spedding M, Stahl SM. A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol. 2014 Jul;24(7):1005-14. doi: 10.1016/j.euroneuro.2013.08.004. Epub 2013 Sep 18. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	NbN influence on medical students views on psychiatry	To examine if Neuroscience-based Nomenclature (NbN) as a teaching-tool for medical students affects their views about the scientific foundation of psychiatry and psychopharmacology.	May-September 2020
Secondary	NbN influence on choosing psychiatry as a profession	To examine whether the use of Neuroscience-based Nomenclature (NbN) in the teaching of psychopharmacology can improve medical students' views on choosing a career in psychiatry.	May-September 2020